Gliomas were less rare among women who used progestin-only than combined oral contraceptive pills.
As gliomas are less common among women than men, female sex hormones have been hypothesized to protect against development of this malignancy. To explore associations between glioma incidence and use of hormonal contraception, researchers conducted a case-control study of all premenopausal Danish women with gliomas diagnosed between 2000 and 2009.
Among 317 identified cases and 2126 age-matched controls, women who developed gliomas had significantly greater odds of reporting long-term use of progestin-only pills and slightly increased odds of prior use of combination pills. Although analyses were adjusted for years of schooling and treatment for allergic conditions, which are inversely associated with glioma risk, data on tobacco use or obes…
Reviewing Author
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine